Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).

Abstract:

:Cancer stem cells (CSCs), which have the potential for self-renewal, differentiation and de-differentiation, undergo epigenetic, epithelial-mesenchymal, immunological and metabolic reprogramming to adapt to the tumor microenvironment and survive host defense or therapeutic insults. Intra-tumor heterogeneity and cancer-cell plasticity give rise to therapeutic resistance and recurrence through clonal replacement and reactivation of dormant CSCs, respectively. WNT signaling cascades cross-talk with the FGF, Notch, Hedgehog and TGFβ/BMP signaling cascades and regulate expression of functional CSC markers, such as CD44, CD133 (PROM1), EPCAM and LGR5 (GPR49). Aberrant canonical and non-canonical WNT signaling in human malignancies, including breast, colorectal, gastric, lung, ovary, pancreatic, prostate and uterine cancers, leukemia and melanoma, are involved in CSC survival, bulk-tumor expansion and invasion/metastasis. WNT signaling-targeted therapeutics, such as anti-FZD1/2/5/7/8 monoclonal antibody (mAb) (vantictumab), anti-LGR5 antibody-drug conjugate (ADC) (mAb-mc-vc-PAB-MMAE), anti-PTK7 ADC (PF-06647020), anti-ROR1 mAb (cirmtuzumab), anti-RSPO3 mAb (rosmantuzumab), small-molecule porcupine inhibitors (ETC-159, WNT-C59 and WNT974), tankyrase inhibitors (AZ1366, G007-LK, NVP-TNKS656 and XAV939) and β-catenin inhibitors (BC2059, CWP232228, ICG-001 and PRI-724), are in clinical trials or preclinical studies for the treatment of patients with WNT-driven cancers. WNT signaling-targeted therapeutics are applicable for combination therapy with BCR-ABL, EGFR, FLT3, KIT or RET inhibitors to treat a subset of tyrosine kinase-driven cancers because WNT and tyrosine kinase signaling cascades converge to β-catenin for the maintenance and expansion of CSCs. WNT signaling-targeted therapeutics might also be applicable for combination therapy with immune checkpoint blockers, such as atezolizumab, avelumab, durvalumab, ipilimumab, nivolumab and pembrolizumab, to treat cancers with immune evasion, although the context-dependent effects of WNT signaling on immunity should be carefully assessed. Omics monitoring, such as genome sequencing and transcriptome tests, immunohistochemical analyses on PD-L1 (CD274), PD-1 (PDCD1), ROR1 and nuclear β-catenin and organoid-based drug screening, is necessary to determine the appropriate WNT signaling-targeted therapeutics for cancer patients.

journal_name

Int J Oncol

authors

Katoh M

doi

10.3892/ijo.2017.4129

subject

Has Abstract

pub_date

2017-11-01 00:00:00

pages

1357-1369

issue

5

eissn

1019-6439

issn

1791-2423

journal_volume

51

pub_type

杂志文章,评审
  • Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in human cancer cell lines.

    abstract::Conventional chemotherapy produces varying degrees of response in patients with many advanced cancers and has significant side effects. Receptors for luteinizing hormone-releasing hormone (LH-RH) are present in a high percentage of human ovarian, prostatic, breast and endometrial tumors and targeted chemotherapy based...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.12.3.671

    authors: Lamharzi N,Halmos G,Armatis P,Schally AV

    更新日期:1998-03-01 00:00:00

  • Allelic imbalance and microsatellite instability in plasma DNA released from polyclonal pancreatic adenocarcinoma.

    abstract::Evidence of circulating soluble DNA in blood-stream of cancer patients has emerged. Because the plasma DNA is largely derived from cancer cells, genetic analysis of plasma DNA is important to understand the molecular events occurred in cancer patient. Seven microsatellite markers in the soluble plasma DNA from patient...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.21.5.949

    authors: Moriyama H,Matsubara N,Kanbara T,Mori M,Matsuoka J,Yoshino T,Takakura N,Shimizu K,Takaka N

    更新日期:2002-11-01 00:00:00

  • Iodine‑131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinoma.

    abstract::Cholangiocarcinoma (CC) is an aggressive liver tumor with limited therapeutic options. Natrium‑iodide symporter (NIS) mediates the uptake of iodine by the thyroid, representing a key component in metabolic radiotherapy using iodine‑131 (131I) for the treatment of thyroid cancer. NIS expression is increased in CC, prov...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2020.4957

    authors: Brito AF,Abrantes AM,Teixo R,Pires AS,Ribeiro AC,Ferreira RF,Mascarenhas A,Puga T,Laranjo M,Caramelo F,Boin I,Jefferson DM,Gonçalves C,Martins R,Tavares I,Ribeiro IP,Sarmento-Ribeiro AB,Carreira IM,Souza D,Tralhão J

    更新日期:2020-03-01 00:00:00

  • Newer vascular targets: endosialin (review).

    abstract::The identification of cell surface markers expressed selectively by tumor vasculature is challenging. To get as close to the human disease as possible, investigators have isolated endothelial cells from fresh human tumor specimens and subjected them to RNA-based gene expression analysis. The data indicate that there a...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:

    authors: Teicher BA

    更新日期:2007-02-01 00:00:00

  • Downregulation of VEGF expression attenuates malignant biological behavior of C6 glioma stem cells.

    abstract::Several lines of direct evidence show that gliomas express high levels of vascular endothelial growth factor (VEGF). VEGF can promote the growth of gliomas through angiogenesis. It is believed that gliomas originate in the brain tumor stem cells (BTSCs). However, the direct effect of VEGF on the biological behavior of...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2331

    authors: Li Q,Qiao G,Ma J,Li Y

    更新日期:2014-05-01 00:00:00

  • Gestational trophoblastic disease - experience of the sheffield (United-kingdom) supraregional screening and treatment service.

    abstract::Abstract. The gestational trophoblastic diseases (GTD) are uncommon complications of pregnancy. The UK GTD registration scheme offers specialist facilities for screening and treatment. In Sheffield about 5% of all patients monitored require chemotherapy. The successful treatment - almost 100% cure - of these patients ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Sheridan E,Hancock B,Smith S,Dorreen M,Neal F,Pennington G,Millar D

    更新日期:1993-08-01 00:00:00

  • miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors.

    abstract::An altered expression of microRNAs (miRNAs) contributes both to the development of cancer and to the progression of the disease. Malignant tumours and tumour cell lines have widespread deregulated expressions of miRNAs compared to normal tissues. In this study, we investigated the expression profiles of 340 mammalian ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1420

    authors: D'Urso PI,D'Urso OF,Storelli C,Mallardo M,Gianfreda CD,Montinaro A,Cimmino A,Pietro C,Marsigliante S

    更新日期:2012-07-01 00:00:00

  • [Corrigendum] All-trans retinoic acid restored the osteogenic ability of BMP9 in osteosarcoma through the p38 MAPK pathway.

    abstract::Subsequently to the publication of the above paper, the authors have realized that the images presented in Fig. 1A were selected erroneously (essentially, the images for group 'AdBMP9 +++' were chosen to represent the group 'AdGFP'). A corrected version of Fig. 1, including the correct data for the experiments depicte...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4817

    authors: Wu N,Li R,Meng Z,Nie M,Chen Q,He B,Deng Z,Yin L

    更新日期:2019-08-01 00:00:00

  • Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.

    abstract::Cell division cycle 20 (CDC20) encodes a regulatory protein interacting with the anaphase-promoting complex/cyclosome (APC/C) in the cell cycle and plays important roles in tumorigenesis and progression of multiple tumors. The present study aimed to investigate the clinical significance of CDC20 in hepatocellular carc...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2559

    authors: Li J,Gao JZ,Du JL,Huang ZX,Wei LX

    更新日期:2014-10-01 00:00:00

  • IL-4 and IL-10 synergistically inhibit survival of human blood monocytes supported by GM-CSF.

    abstract::Interleukin (IL)-4 and IL-10 have a wide variety of activities in the immune system. We re-evaluated the action of IL-4 and IL-10 on human blood monocytes, myeloid dendritic cell (DC1) precursors, using a serum-free culture system. Both IL-4 and IL-10 inhibited the survival of CD14+ monocytes supported by granulocyte-...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Miyashita H,Katayama N,Fujieda A,Shibasaki T,Yamamura K,Sugimoto Y,Miyata E,Ohishi K,Nishii K,Masuya M,Shiku H

    更新日期:2005-03-01 00:00:00

  • Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model.

    abstract::Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to induce apoptosis in a variety of cancer cells, including colon, prostate, breast and leukemia. Among them, aspirin, a classical NSAID, shows promise in cancer therapy in certain types of cancers. We hypothesized that aspirin...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1304

    authors: Hossain MA,Kim DH,Jang JY,Kang YJ,Yoon JH,Moon JO,Chung HY,Kim GY,Choi YH,Copple BL,Kim ND

    更新日期:2012-04-01 00:00:00

  • Nuclear-DNA content and p53 immunostaining in oral squamous-cell carcinoma - an analysis of a consecutive 10-year material.

    abstract::In a retrospective analysis of 91 consecutive oral carcinomas we reviewed all patient records and weighed clinicopathological parameters against the results of image DNA cytometry and p53 immunhistochemical staining of the initial diagnostic biopsies. Eighty-seven percent of the biopsies were either aneuploid or nondi...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.5.4.915

    authors: Hogmo A,Munckwikland E,Kuylenstierna R,Lindholm J,Auer G

    更新日期:1994-10-01 00:00:00

  • 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.

    abstract::3F8 is an IgG3 murine monoclonal antibody directed against the ganglioside GD2. In a phase II study, 3F8 was administered i.v. to 16 patients (pts) who had stage 4 neuroblastoma. Response was seen in bony lesions (2 of 7 pts) and marrow (3 of 8 pts). Acute toxicities of pain, fever, urticaria, hypertension, hypotensio...

    journal_title:International journal of oncology

    pub_type: 临床试验,杂志文章

    doi:10.3892/ijo.12.6.1299

    authors: Cheung NK,Kushner BH,Yeh SD,Larson SM

    更新日期:1998-06-01 00:00:00

  • miR‑300 regulates tumor proliferation and metastasis by targeting lymphoid enhancer‑binding factor 1 in hepatocellular carcinoma.

    abstract::Accumulating evidence indicates that microRNAs (miRNAs) have a critical role in cell proliferation and metastasis in hepatocellular carcinoma (HCC). However, the effect of miR‑300 on the development and progression of HCC remains unclear. In the present study, it was observed that miRNA (miR)‑300 expression was signif...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4715

    authors: Chen Y,Guo Y,Li Y,Yang J,Liu J,Wu Q,Wang R

    更新日期:2019-04-01 00:00:00

  • Cholesterol metabolism in drug‑resistant cancer (Review).

    abstract::Cancer represents a severe challenge to healthcare systems and individuals worldwide. The development of multiple drug resistance is a major issue regarding cancer therapy, which can result in the progression of disease. Cholesterol is a major constituent of cell membranes and participates in the regulation of several...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2020.5124

    authors: Yan A,Jia Z,Qiao C,Wang M,Ding X

    更新日期:2020-09-22 00:00:00

  • The role of gC1qR in regulating survival of human papillomavirus 16 oncogene-transfected cervical cancer cells.

    abstract::Human papillomavirus 16 (HPV-16) is strongly associated with the development of 50% of cervical cancers. The E6 and E7 proteins encoded by high-risk HPV types are associated with the immune evasion of cervical cancer cells, but the mechanism is poorly understood. The purpose of this study was to investigate whether ce...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.1108

    authors: Gao LJ,Gu PQ,Fan WM,Liu Z,Qiu F,Peng YZ,Guo XR

    更新日期:2011-11-01 00:00:00

  • Molecular cloning and characterization of human WNT5B on chromosome 12p13.3 region.

    abstract::WNT signaling pathway plays a key role in carcinogenesis and embryogenesis. We have cloned and characterized the human WNT5B. Overlapping WNT5B cDNAs, containing 1080-bp ORF, were isolated. WNT5B encoded a 359-amino-acid polypeptide with the N-terminal signal peptide, four N-linked glycosylation sites, and consensus a...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.19.2.347

    authors: Saitoh T,Katoh M

    更新日期:2001-08-01 00:00:00

  • Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.

    abstract::One of the major obstacles in curing prostate cancer is the development of drug resistance. It is not only imperative to discover the molecular basis of resistance but also to find therapeutic agents that can disrupt the resistant pathways. Tumor necrosis factor TNF-related apoptosis-inducing ligand TRAIL-like ligands...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Festuccia C,Gravina GL,D'Alessandro AM,Millimaggi D,Di Rocco C,Dolo V,Ricevuto E,Vicentini C,Bologna M

    更新日期:2008-08-01 00:00:00

  • Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.

    abstract::A p53 functional analysis system, which can identify the types of abnormality of p53, such as loss of function, dominant negative function, or gain of oncogenic function, is now required. In this study, we examined the functional diversity of several mutations of p53 derived from human head and neck cancer cells. The ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Kawamata H,Omotehara F,Nakashiro K,Uchida D,Shinagawa Y,Tachibana M,Imai Y,Fujimori T

    更新日期:2007-05-01 00:00:00

  • Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis.

    abstract::Plakoglobin is a tumor suppressor gene in lung cancer; however, the mechanism by which it is downregulated in lung cancer is largely unknown. The aim of the present study was to investigate whether histone deacetylases (HDACs) regulate plakoglobin expression in lung cancer. The effects of overexpression or knockdown o...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4682

    authors: Sang Y,Sun L,Wu Y,Yuan W,Liu Y,Li SW

    更新日期:2019-03-01 00:00:00

  • Differential modulation of cellular and viral promoters by p73 and p53.

    abstract::p73 has been shown to transcriptionally activate genes positively responsive to wild-type p53. In order to undertake a comparative study of functions of p53 and p73 we have cloned the cDNA of p73 from MCF-7 cells. Adenovirus onco-protein E1A inhibits the transactivation by p73; a deletion mutant of E1A incapable of in...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Deb D,Lanyi A,Scian M,Keiger J,Brown DR,Le Roith D,Deb SP,Deb S

    更新日期:2001-02-01 00:00:00

  • Conjugated linoleic acid induces monocytic differentiation of murine myeloid leukemia cells.

    abstract::Conjugated linoleic acid (CLA) refers to a group of naturally occurring positional and geometrical conjugated dienoic isomers of linoleic acid (C18:2), of which the cis-9,trans-11 (c9,t11) and trans-10,cis-12 (t10,c12) isomers predominate. Accumulating evidence has demonstrated that CLA isomers are capable of inhibiti...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Lui OL,Mak NK,Leung KN

    更新日期:2005-12-01 00:00:00

  • Nuclear morphometry for predicting cervical metastatic potential in laryngeal squamous-cell carcinoma.

    abstract::Quantitative nuclear morphometry (QNM) provides a reliable, reproducible method for measuring the degree of nuclear pleomorphism, a qualitative parameter widely incorporated into histopathological grading schemes. Nuclear shape has successfully been shown to predict primary prostate adenocarcinoma metastatic potential...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.7.3.673

    authors: Donat T,Sakr W,Pienta K

    更新日期:1995-09-01 00:00:00

  • Non-B, non-C hepatocellular carcinoma (Review).

    abstract::Although most hepatocellular carcinoma (HCC) is related to viral infection, there is a substantial population of HCC patients (5-20%) who are negative for both markers of hepatitis B virus and hepatitis C virus infection [non-B, non-C (NBNC) hepatitis] in Japan and the incidence of NBNC-HCC has recently tended to incr...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.2013.2061

    authors: Nishikawa H,Osaki Y

    更新日期:2013-11-01 00:00:00

  • Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer.

    abstract::Telomerase activity (TA) is associated with most malignant human tumors but is not detected in normal somatic cells with a few exceptions. Three major subunits (hTR, hTP1 and hTERT) of telomerase have been identified. To investigate the clinical implications of the mRNA detection of these components as useful diagnost...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.19.5.1063

    authors: Lee BK,Diebel E,Neukam FW,Wiltfang J,Ries J

    更新日期:2001-11-01 00:00:00

  • Percutaneous ethanol injection therapy for hepatocellular-carcinoma (review).

    abstract::Recently, ultrasound-guided percutaneous ethanol injection therapy (PEIT) has been widely performed in the treatment of hepatocellular carcinoma. Histopathologic examinations after the therapy have revealed that PEIT can destroy the tumor completely in most cases. Findings in imaging modalities and serum tumor marker ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2.4.669

    authors: Shiina S,Niwa Y,Shiratori Y,Terano A,Omata M

    更新日期:1993-04-01 00:00:00

  • Differential susceptibility of metastatic and primary oral cancer cells to TRAIL-induced apoptosis.

    abstract::TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) preferentially induces apoptosis of cancer cells without toxicity in normal cells. TRAIL plays an important role in host immune surveillance against tumor metastasis. Cathepsin B (CB) is a mediator of apoptosis whose activity is regulated by its inhibitor...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Vigneswaran N,Wu J,Nagaraj N,Adler-Storthz K,Zacharias W

    更新日期:2005-01-01 00:00:00

  • Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters.

    abstract::Recent studies have shown that chromosome 8p21-22 is the main site of frequent loss of heterozygosity (LOH) in breast cancers. However, the detailed molecular analysis of chromosome 8 so far in breast cancer has been variable. Most of the literature pertaining to LOH in breast cancer is mainly on short arm of chromoso...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.12.4.811

    authors: Dahiya R,Perinchery G,Deng G,Lee C

    更新日期:1998-04-01 00:00:00

  • How surgeon age affects post-treatment surveillance strategies for melanoma patients.

    abstract::The intensity of post-treatment melanoma patient follow-up varies widely among physicians. We investigated whether physician age accounts for the observed variation in surveillance intensity among plastic surgeons. A custom-designed questionnaire was mailed to USA and non-USA surgeons, all of whom were members of the ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.19.1.175

    authors: Margenthaler JA,Virgo KS,Johnson DY,Sugarbaker EM,Handler BS,Johnson FE

    更新日期:2001-07-01 00:00:00

  • Organophosphorous pesticides and estrogen induce transformation of breast cells affecting p53 and c-Ha-ras genes.

    abstract::Cancer progression has been associated with an increase in genomic instability indicated by inactivation of tumor suppressor genes and activation of oncogenes. Epidemiological and experimental evidence has implicated estrogens in the etiology of breast cancer. To study environmental organophosphorous pesticides is of ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo_00000421

    authors: Calaf GM,Echiburu-Chau C,Roy D

    更新日期:2009-11-01 00:00:00